Table 2.

Patient assistance program (PAP) of pharmaceutical companies to increase access to six innovative anti-cancer medicines.

Name	Indication	PAP
Trastuzumab	Breast cancer	8 vials paid by the PAP after 6 vials paid by patient
Bevacizumab	Colorectal cancer	Free after payment of 4 M
Sorafenib	Kidney cancer	Free after payment of 3 M
Bortezomib	Mantle cell lymphoma	Company donates 6 treatment courses after 3 treatment courses paid
Erlotinib	Non-small cell lung cancer	Free after payment of 4 M
Fulvestrant	Breast cancer	Company donates 3 M after 3 M paid

PAP, patient assistance program.

M, Months.